Research Forensic Library

A program of the Global Forensic and Justice Center at Florida International University

Browse by category

Browse collections

Search everything

European Monitoring Centre for Drugs and Drug Addiction

TitleAuthorsSourceLinkYear
Complexity and differentiation of the MDMA retail market: insights from the European Web Survey on DrugsLies GremeauxEMCDDA; 2022www.emcdda.europa.eu/publications/insights/web-surveys/complexity-differentiation-mdma-retail-market-insights-european-web-survey-drugs_en2022
Comparing two approaches for estimating cannabis consumption: raking and regressionJonathan P. Caulkins, Kyle Furlong, Brandon McComas, Martha Nogueira Domingues, Aatir Siddique and Beau KilmerEMCDDA; 2022www.emcdda.europa.eu/publications/insights/web-surveys/comparing-approaches-estimating-cannabis-consumption-raking-regression_en2021
Sources of cannabis acquisition by country and frequency of use in the European web survey on drugsMike Vuolo and João MatiasEMCDDA; June 2022www.emcdda.europa.eu/publications/insights/web-surveys/sources-cannabis-acquisition-country-frequency-use-european-web-survey-drugs_en2022
New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning SystemEMCDDA; 38pp; June 2022www.emcdda.europa.eu/publications/rapid-communication/update-eu-early-warning-system-2022_en2022
New benzodiazepines in Europe – a reviewEMCDDA; 48pp; 2021www.emcdda.europa.eu/publications/rapid-communications/new-benzodiazepines-europe-review_en2021
3-CMC: Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)EMCDDA; 90pp; 2022www.emcdda.europa.eu/publications/risk-assessments/3-cmc_en2022
3-MMC: Report on the risk assessment of 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)EMCDDA; 2022www.emcdda.europa.eu/publications/risk-assessments/3-mmc_en2022
Methamphetamine from Afghanistan: signals indicate that Europe should be better preparedEuropean Monitoring Centre for Drugs and Drug Addiction; September 2021www.emcdda.europa.eu/system/files/publications/14071/EMCDDA-Methamphetamine-from-Afghanistan.pdf2021
Synthetic cannabinoids in Europe – a reviewV. Auwärter, J. de Morais, A. Gallegos, M. Evans-Brown, R. Christie, R. Jorge, R. SedefovEMCDDA; September 2021www.emcdda.europa.eu/system/files/publications/14035/Synthetic-cannabinoids-in-Europe-EMCDDA-technical-report.pdf2021
Global Forensic and Justice Center

11200 SW 8th Street
Miami, FL 33199
Contact Us